Group
Rare Diseases
4 themes21 tickers
10D rank#109of 134 groups
Peek into the magic of rare disease healthcare. Our group splits into gene, RNA, and protein therapy themes, plus CNS/neuro breakthroughs. With supportive policies and expanding patient access, this market is buzzing with innovative platforms and growth.
Themes in this group
Build 20260806T082229
| Rare Diseases '25: Gene Therapy & Genetic Med | 7 | $3.55B | $24.83B | -1.08% | +1.09% | -14.46% | +1.66% | +25.00% | +47.82% | +16.84% | -31.92% | +23.37% | +41.35% | +0.73% | -2.78% |
| Rare Diseases '25: CNS/Neuro | 5 | $27.71B | $138.54B | +0.65% | +0.14% | -6.07% | +3.66% | +30.97% | +84.44% | +33.77% | +78.44% | +13.16% | +96.65% | +0.14% | +3.99% |
| Rare Diseases '25: RNA Therapy & Protein Mod | 5 | $10.74B | $53.69B | +0.12% | -0.13% | -7.61% | +3.04% | -17.03% | +22.87% | +20.98% | +129.62% | -7.48% | +55.46% | -14.03% | -0.40% |
| Rare Diseases '25: Platform Biotechs & Pipelines | 4 | $26.65B | $106.61B | +0.34% | -2.02% | -0.42% | +1.08% | +18.19% | +63.98% | +111.12% | +91.32% | +14.31% | +89.53% | +5.83% | +3.97% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary